What is the recommended dose of cefuroxime for an adult patient with normal kidney function and an uncomplicated urinary tract infection (UTI), 750mg three times a day (tds) or 1.5g tds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefuroxime Dosing for UTI: 750mg TDS is the Recommended Dose

For uncomplicated urinary tract infections in adults with normal renal function, cefuroxime 750mg three times daily (every 8 hours) is the FDA-approved and guideline-supported dose, not 1.5g TDS. 1

FDA-Approved Dosing for UTI

The FDA label for cefuroxime explicitly states that for uncomplicated urinary tract infections, a 750mg dose every 8 hours is recommended 1. The higher dose of 1.5g every 8 hours is reserved for severe or complicated infections, bone and joint infections, and life-threatening infections 1.

Guideline Support for Oral Cefuroxime

  • The European Association of Urology guidelines recommend oral cephalosporins like cefuroxime 500mg twice daily for 10-14 days as step-down therapy for complicated UTIs 2
  • For uncomplicated UTIs, research supports cefuroxime 250mg three times daily for 7 days as clinically and bacteriologically effective 3

Key Distinctions by Infection Severity

Uncomplicated UTI (cystitis):

  • Standard dose: 750mg every 8 hours IV/IM 1
  • Oral alternative: 250mg three times daily 3

Complicated UTI:

  • Standard dose: 1.5g every 8 hours IV 1
  • Oral step-down: 500mg twice daily for 10-14 days 2, 4

Severe/life-threatening infections:

  • Maximum dose: 1.5g every 6 hours (not every 8 hours) 1

Clinical Efficacy Data

  • Research demonstrates that cefuroxime 250mg three times daily achieves 75% bacteriological cure rates in uncomplicated UTI, with clinical cure in 100% of patients 3
  • The drug shows excellent activity against common uropathogens including E. coli (85% of cases) and Klebsiella pneumoniae 3
  • Oral bioavailability is 68% after a meal, with peak plasma concentrations of 7.9 mg/L after 500mg dosing 5

Critical Dosing Errors to Avoid

  • Never use 1.5g TDS for uncomplicated UTI - this represents overdosing and is not supported by FDA labeling or clinical evidence 1
  • Do not use doses smaller than 750mg every 8 hours for standard UTI - the FDA label explicitly states that doses smaller than indicated should not be used 1
  • Oral cephalosporins achieve significantly lower blood and urinary concentrations than IV route, so ensure appropriate route selection 6

Renal Dose Adjustments

For patients with renal impairment, dosing must be reduced 1:

  • Creatinine clearance >20 mL/min: 750mg-1.5g every 8 hours
  • Creatinine clearance 10-20 mL/min: 750mg every 12 hours
  • Creatinine clearance <10 mL/min: 750mg every 24 hours
  • Post-hemodialysis: Give additional 750mg dose after dialysis 1

Treatment Duration

  • Uncomplicated UTI: 7-10 days 5, 3
  • Complicated UTI: 10-14 days 2, 4
  • Continue therapy for minimum 48-72 hours after patient becomes asymptomatic 1

When to Consider Alternative Agents

  • If local fluoroquinolone resistance is <10%, ciprofloxacin 500-750mg twice daily for 7 days or levofloxacin 750mg once daily for 5 days are preferred first-line options for uncomplicated pyelonephritis 6, 7
  • Oral β-lactams including cefuroxime generally achieve lower efficacy rates than fluoroquinolones for complicated UTIs 4
  • If no clinical improvement within 72 hours on cefuroxime, reevaluate and consider imaging to rule out complications 4

References

Guideline

Complicated Urinary Tract Infections Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cefuroxime Treatment for Complicated Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Cefuroxime axetil.

International journal of antimicrobial agents, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Regimen for UTI in Patients with Multiple Antibiotic Allergies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.